The statin dictatorship: Preventive health or pharmaceutical business?
Modern medicine faces growing skepticism toward the mass prescription of cholesterol drugs, a practice many patients now view as a lifelong sentence imposed by the system. The paradox is clear: individuals who normalize blood pressure through diet and lifestyle changes face persistent clinical insistence on chronic medication, under the argument that their own body produces excess lipids that must be pharmacologically suppressed.
The conflict between physiology and clinical protocol
The core of the technical debate lies in distinguishing cholesterol as a risk marker from cholesterol as an essential element for testosterone production and cellular maintenance. While official protocol advocates systematic LDL reduction via statins, an analytical current argues that the real problem is not cholesterol presence but its glycation process, derived from excessive sugar and refined carbohydrate consumption. Statin prescription, far from being seen as harmless, is questioned for side effects, including increased blood glucose, which could lead to cascading pharmacological dependence.
Incentives and the role of the industry
Patient distrust of medical consultation is not unfounded. The history of incentives—from lab-funded trips and conferences to commercial pressure on doctors—has eroded the health system's authority. The suspicion that 80% of the elderly population is a candidate for chronic medication suggests a business model based on patient retention rather than a public health strategy aimed at eradicating the pathology. In this scenario, the informed patient begins to see the consultation as a formality validating a dogma that prioritizes pharmacopeia over real metabolic management.
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication.
Read the full discussion (247 replies).
We analyze prices, sound quality, battery life, and health risks of Bluetooth headphones. Data suggests wired models still offer superior value and longevity.